Tumors with the highest rates of E-Cadherin loss included Merkel cell carcinoma, anaplastic thyroid carcinoma, lobular carcinoma of the breast, and sarcomatoid and small cell neuroendocrine carcinomas of the urinary bladder. The gene discussed is CDH1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.